Amicus Therapeutics, Inc. - Rasio total nilai perusahaan marang pendapatan FOLD

Logo perusahaan publik Amicus Therapeutics, Inc. (FOLD)

The EV/Revenue multiple for Amicus Therapeutics (FOLD) reflects current market sentiment, with the 7408.71 mark indicating the current state. Business growth is constrained by the number of patients with rare genetic pathologies and FDA decisions. The orphan drug status of the medications ensures high margins and a stable cash flow. However, geopolitical fragmentation and sanctions complicate international logistics and scientific research.

FOLD Amicus Therapeutics: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 09.05.2026

FOLD (Amicus Corp): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental perusahaan:FOLD (Amicus Therapeutics)
Produk seri Amicus Pharma

For Amicus Therapeutics (FOLD), this indicator reflects the enterprise value of the business, accounting for net debt, relative to the volume of generated sales. By analyzing the current enterprise value-to-revenue ratio, an investor can assess how effectively the scaling of Pompe disease therapy justifies the company's capitalization, where an increasing multiple signals expectations for the accelerated commercial rollout of the drug.

Analisis pesaing Amicus Therapeutics

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)